Can axillary node clearance (ANC) be avoided in selected clinically node positive breast cancers (cN+BC) after neoadjuvant therapy (NAT)?. Issue 5 (May 2017) - Giono, Ilaria; Lobo, Cheryl; Gattuso, Jennifer; Franks, Joanna; Stanilov, Noyko; Carpenter, Robert